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Original article
Arousals Are Frequent and Associated With Exacerbated 
Blood Pressure Response in Patients With Primary 
Hypertension
Carlos E. V. Garcia,1 Luciano F. Drager,2 Eduardo M. Krieger,2 Carlos E. Negrão,2,3 Luiz A. Bortolotto,2 
Geraldo Lorenzi-Filho,2 and Linda M. Ueno4
Background
Spontaneous arousals are relatively common during sleep, and induce 
hemodynamic responses. We sought to investigate the frequency and 
magnitude of blood pressure (BP) increases triggered by spontaneous 
arousals in patients with primary hypertension.
Methods
We conducted a study in which we divided 18 nonobese, sedentary 
adults without sleep-disordered breathing into two groups, consisting 
of: (i) hypertensive (HT, n = 8) patients; and (ii) normotensive (NT, n = 10) 
controls. The groups were matched for age and body mass index. All 
subjects underwent full polysomnography with simultaneous monitor-
ing of heart rate (HR) and beat-by-beat BP. Each subject’s BP and HR 
were analyzed immediately before BP peaks triggered by spontaneous 
arousals during stage 2 of nonrapid eye movement sleep.
results
The total sleep time, sleep efficiency, and sleep structure in the two 
study groups were similar. In contrast, the number of arousals was 
significantly higher in the HT than in the NT group, at 25 ± 5 vs. 12 ± 3 
events/h, respectively (P < 0.05). The HR of the HT and NT groups was 
similar before arousal (65 ± 3 bpm vs. 67 ± 3 bpm, respectively, P < 0.01) 
and increased significantly and similarly in the two groups upon arousal 
(to 79 ± 6 bpm vs. 74 ± 4 bpm, respectively, P < 0.01). Systolic and dias-
tolic BPs were significantly higher throughout sleep in the HT than 
in the NT group. During spontaneous arousals, BP increased in both 
groups (P < 0.05). However, the magnitude of the increase in systolic BP 
was significantly greater in the HT than in the NT group (22 ± 3 mm Hg 
vs. 15 ± 3 mm Hg, P < 0.05).
conclusions
Patients with hypertension who do not have sleep-disordered breath-
ing have an increased cardiovascular burden during sleep, which may 
be due to the greater number of arousals and exacerbated systolic BP 
response that they experience during sleep. These novel findings may 
have cardiovascular implications in patients with hypertension.
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Humans spend a significant proportion of their lives in sleep. 
Sleep may be seen as a period of quiescence of the cardiovas-
cular system with a progressive decrease in heart rate (HR) 
and blood pressure (BP) during nonrapid eye movement 
(NREM) sleep. Rapid eye movement sleep is associated with 
oscillations in BP and HR. However, NREM sleep consti-
tutes more than 75% of total sleep time in healthy individu-
als, and BP is expected to decrease > 10% during sleep.1,2 The 
physiological decrease in BP as evaluated by 24-hour ambu-
latory BP monitoring occurs not only in normotensive (NT) 
individuals, but also in hypertensive (HT) patients.3 Over 
the past three decades, an increasing awareness has occurred 
of the relationship between hypertension and obstructive 
sleep apnea (OSA), a condition characterized by repeti-
tive obstruction of the upper airways, causing intermittent 
hypoxia and arousals from sleep.4 A significant proportion 
of HT patients have OSA5 that may lead to nondipping of BP 
during sleep.6 However, little attention has been given to the 
study of sleep in HT patients without OSA.
There is growing evidence that HT patients frequently 
have reduced sleep time and poor sleep quality that in the-
ory may participate in a vicious cycle and further contrib-
ute to poor BP control.3,7-8 Using a beat-by-beat technique, 
we have recently shown similar reductions in BP in NREM 
sleep in NT and HT individuals in whom sleep-disordered 
breathing was carefully excluded.9 However, in study show-
ing such reductions, neither the frequency of arousals not 
the BP response to arousals were investigated. In order to 
accomplish this goal, we reanalyzed, in the present study, the 
data from the previous study.9 In addition, because of insuf-
ficient BP data during spontaneous arousals in 7 subjects in 
stage 2 (N2) of NREM sleep, we included 6 new participants 
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in the present study. The hypothesis was that among indi-
viduals without OSA or other sleep disturbances, patients 
with primary hypertension not treated with medication have 
greater sleep fragmentation and a greater increase in BP dur-
ing spontaneous arousal in N2 of NREM sleep than do NT 
individuals.
Methods
subjects
We studied both male and female subjects. All of the 
female subjects were taking oral contraceptives (low doses 
of ethinyl estrogen and progestin). Study subjects who had a 
history of circadian desynchrony (e.g. shift workers) or peri-
odic leg movements were excluded. Study subjects who were 
older than 50 years or had a body mass index (BMI) > 27 kg/
m2, diabetes mellitus, cerebrovascular disease, arrhythmias, 
heart failure, valvular heart disease, renal failure, renovascu-
lar hypertension, or a history of smoking or alcohol abuse 
(2 or more drinks per day) were excluded from the study. 
Because the study focused on subjects without sleep-dis-
ordered breathing, all of the subjects included in the study 
were selected according to a history of a low risk of OSA 
and an absence of daytime somnolence, as evaluated with 
the Berlin Questionnaire10 and Epworth sleepiness scale,11 
respectively. The Berlin Questionnaire classifies a subject as 
having a low or high risk of OSA on the basis of 3 categories, 
which include snoring characteristics, tiredness, and obesity 
or hypertension. A low risk of OSA with this questionnaire 
is based on none or only one of its categories being positive. 
The Epworth sleepiness scale asks subjects to rate the prob-
ability of their falling asleep in 8 different daily situations, 
on a scale of increasing probability ranging from 0 to 3 for 
each situation. A total score below 10 is consistent with an 
absence of excessive daytime sleepiness and therefore with a 
low risk for the presence of OSA.
The NT controls for the study were recruited from the 
Heart Institute staff or their relatives, and were selected on 
the basis of having similar values of BMI. Hypertension 
was carefully excluded in the NT control group. To exclude 
masked hypertension or “white-coat” hypertension, all NT 
subjects had at least three office BP measurements made 
by one of the study investigators (L.F.D.), in addition to 
three out-of-office BP measurements. The HT individu-
als were outpatients recruited from the Hypertension 
Unit of the Heart Institute of the University of São Paulo 
Medical School who met the exclusion criteria for the 
study. Secondary causes of hypertension12 were excluded 
through medical history, physical examination, and 
screening laboratory tests of the entire HT group (esti-
mated glomerular filtration rate, urine-sediment exami-
nation, captopril renal scintigraphy, and measurement of 
plasma renin activity, aldosterone, thyroid-stimulating 
hormone, catecholamines, and 24-hour urinary metane-
phrines). All HT patients had previously been diagnosed 
as having stage 1 or 2 hypertension according to the cur-
rent guidelines for this.12 Patients with resistant, acceler-
ated (defined as a recent, significant increase in BP over 
baseline BP in association with target-organ damage based 
on funduscopic examination, such as flame-shaped hem-
orrhages or soft exudates, but without papilledema), or 
malignant hypertension were excluded. Antihypertensive 
medications were withdrawn 2 weeks before the study, 
as described in the report of our previous study9 and by 
others.13,14 Antihypertensive medications included diu-
retics (62.5%), angiotensin-converting-enzyme inhibitors 
or angiotensin II receptor blockers (62.5%), and calcium-
channel blockers (12.5%).
experimental protocol
The study subjects were asked to continue their usual daily 
activities before the experiment, including regular sodium 
intake. They were asked to avoid caffeine, alcohol, and naps 
on the day of the study. All participants were admitted to the 
sleep laboratory at 8PM. After a physical examination, mon-
itoring equipment was attached, and study subjects went to 
bed around 10PM.
Measurements
A standard overnight polysomnographic study 
(EMBLA, Flaga hf. Medical Devices, Reykjavik, Iceland) 
was performed as previously described.15,16 Respiratory 
signals were recorded by a piezoelectric thoracic belt 
placed around the patient’s upper abdomen. No sleep-
inducing medications were administered before the poly-
somnographic study.
cardiovascular monitoring
In addition to standard polysomnography, all subjects 
underwent a continuous and simultaneous electrocar-
diographic recording of their beat-by-beat HR, BP, and 
respiratory signals. Respiratory signals were recorded 
with a piezoelectric thoracic belt placed around the 
patient’s upper abdomen. These signals were recorded 
continuously with an analog-to-digital multichannel sig-
nal conditioner and amplifier/filter (AT/MCA-CODAS, 
DATAC Instruments, Akron, OH). Blood pressure was 
measured with the Portapres system (TNO Biomedical 
Instrumentation, Amsterdam, The Netherlands), allowing 
continuous, indirect, noninvasive measurements of beat-
by-beat BP. This method has been shown to accurately 
estimate intra-arterial BP through its use of a height-cor-
rection unit to compensate for measurement of BP in the 
finger.17 For the subject’s comfort, the Portapres system 
alternates its measurements among different fingers every 
30 minutes. We considered for analysis only stable peri-
ods of measured BP, excluding periods of body movement 
through polysomnography. All recordings (polysomno-
graphic and cardiovascular) were synchronized through 
the use of two computers because of the limitation of the 
sample size per channel of the polygraph. The analogical 
signals were sampled at 1,000 Hz per channel and stored 
on a hard disk for subsequent analyses.
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data analysis
Sleep stages were scored according to the criteria of 
Rechtschaffen and Kales18 and Iber et al.19 Apnea was defined 
as a decrease of > 90% for at least 10 seconds in the peak ther-
mal sensor excursion. Hypopnea was defined as a significant 
reduction (> 50%) in respiratory signals for at least 10 sec-
onds in association with an arousal or oxygen desaturation of 
≥ 3%. The apnea–hypopnea index (AHI) was calculated as the 
total number of respiratory events (apneas plus hypopnea) 
per hour of sleep. Study subjects who had an AHI > 5 events 
per hour of sleep were excluded from the study. Arousal from 
sleep was defined as an abrupt increase in the frequency of 
the electroencephalogram, including an increase in the fre-
quency of alpha or theta waves or both and/or frequencies 
exceeding 16 Hz, lasting 3–15 seconds, and preceded by 10 
seconds of stable sleep.19
The polysomnographic records were reviewed particu-
larly in the N2 of NREM sleep. Four spontaneous arousals, 
with a minimum duration of from 3–15 seconds and com-
prising two arousals in the first and two in the last sleep cycle 
during NREM, were selected.
For each spontaneous arousal, beat-by-beat BP and HR 
responses were analyzed from 15 seconds before until 15 sec-
onds after spontaneous arousal. The BP signal was processed 
to detect beat-by-beat values of systolic BP and diastolic BP 
through the use of Windaq software (DATAC Instruments Inc., 
Akron, OH). Heart rate was calculated as beats per minute.
The average systolic and diastolic BP, HR during spontane-
ous arousals, and the average of maximal values for systolic 
and diastolic BP and HR responses in four spontaneous arous-
als occurring in the N2 of NREM sleep were determined for 
all subjects. The magnitude of responses for hemodynamic 
variables was determined for each subject by subtracting the 
mean beginning value from the mean maximal values during 
spontaneous arousal. The time taken to initiate a systolic BP 
response and the time to reach the peak systolic BP response 
during spontaneous arousals were determined for each subject, 
and group means were calculated for the HT and NT groups. 
Additionally, the durations of spontaneous arousals were deter-
mined for each subject and group means were calculated. 
Arousals were identified through visual inspection by the same 
investigator, blinded to the HT and NT groups.
statistical analysis
All calculations were performed with the STATISTICA 
statistical program (StatSoft Inc., Tulsa, OK). Data are pre-
sented as means ± SEM. The chi-squared test was used for 
categorical variables. To compare the hemodynamic patterns 
in the HT and NT study groups across the sleep-arousal 
phases (beginning values and maximal response), analysis 
of variance (ANOVA) with repeated measures was used to 
test the interaction of phase effect and group effect. When 
significance was found, Scheffe’s post hoc comparison was 
used. An unpaired t-test was performed to compare changes 
among groups. A Pearson correlation was done between the 
maximal systolic BP value during arousal and the duration 
of arousal for each study group. A value of P < 0.05 was con-
sidered statistically significant.
results
The characteristics of the study participants are shown in 
Table 1. The two study groups had similar, ages, BMIs, neck 
circumferences, and percentages of white members. The 
sleep parameters of the participants are shown in Table  2. 
The Epworth Sleepiness Score, total sleep time, sleep effi-
ciency, sleep stages, AHI, and awakenings were similar in 
the two groups. Arousals were significantly more frequent 
(P < 0.01) in the HT than in the NT group.
Table 1. Demographic characteristics of study subjects
Variables NT HT P
Male, % 60 38 0.64
White, % 60 67 0.16
Age, years 39 ± 3 36 ± 4 0.75
BMI, kg/m2 23 ± 0.7 24 ± 0.3 0.43
Neck circumference, cm 35 ± 1.0 34 ± 1.1 0.74
Cardiovascular parameters
 Systolic BP, mm Hga 107 ± 3.7 175 ± 6.9 < 0.01*
 Diastolic BP, mm Hga 70 ± 3.1 92 ± 4.8 < 0.01*
 Heart rate, bpm 70 ± 1.8 75 ± 1.8 0.52
*P < 0.05 for differences between groups.
Values are means ± SEM.
aThe blood pressure values correspond to the mean of two office 
blood pressure readings after 2 weeks of withdrawal of antihyper-
tensive medication.
Abbreviations: BMI, body mass index; HT, hypertensive; NT, nor-
motensive; BP, blood pressure.
Table 2. Sleep parameters of study subjects
Variables NT HT P
ESS  6.3 ± 0.9  6.3 ± 0.2 0.96
Total sleep time, min 391 ± 19 340 ± 26 0.14
Sleep efficiency  86 ± 3.0  80 ± 5.2 0.28
Stage 1, %TST  6 ± 1  8 ± 3 0.47
Stage 2, %TST 65 ± 3  62 ± 4 0.65
Stage 3, %TST 13 ± 2 15 ± 4 0.53
REM, %TST 16 ± 1 15 ± 2 0.64
AHI, events/h  2 ± 1 2 ± 1 0.68
Minimal O2 saturation, % 90 ± 1 91 ± 1 0.88
Overall arousals, 
events/h
12 ± 3 25 ± 5 0.03*
Awakenings, events/h    1 ± 0.4  2 ± 0.7 0.64
*P < 0.05 for differences between groups.
Values are in means ± SEM.
Abbreviations: AHI, apnea-hypopnea index; ESS, Epworth 
Sleepiness Score; HT, hypertensive; NT, normotensive; TST, total 
sleep time.
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The hemodynamic data at 15 seconds before arousal from 
the N2 of NREM sleep was different in the HT and NT 
groups. The HT patients had higher systolic (125 ± 5 mm Hg 
vs. 104 ± 4 mm Hg, P = 0.003), diastolic (67 ± 3 mm Hg vs. 
54 ± 2 mm Hg, P = 0.003), and mean BP values (87 ± 4 mm 
Hg vs. 71 ± 2 mm Hg, P  =  0.002) than did the NT group. 
There were no differences in HR in the HT and NT groups 
during the 15 seconds before arousal (66 ± 3 bpm vs. 64 ± 2 
bpm, P = 0.58, respectively).
hemodynamic responses to arousal in normotensive and 
hypertensive subjects
During arousal, systolic BP, diastolic BP, and HR increased 
significantly over their baseline values (immediate values 
before arousal) in both the HT and NT groups (P  <  0.05). 
Both the baseline systolic and diastolic BP and the systolic and 
diastolic BP during arousal were significantly higher in the 
HT than in the NT group (P < 0.05) (Figure 1A and B). No 
differences in HR were found at baseline or during arousal in 
the HT and NT groups (Figure 1C).
Further analysis showed that changes in systolic BP during 
arousal (maximal systolic BP value minus baseline systolic 
BP value) in the HT group were significantly greater than in 
the NT group (22 ± 3 vs. 15 ± 3 mm Hg, P < 0.05) (Figure 1A).
Neither the mean duration of arousal nor the time needed 
to trigger an increase in systolic BP induced by spontaneous 
arousals differed in the HT patients and NT subjects (Table 3). 
However, increased systolic BP was inversely correlated with 
the duration of arousal in the HT patients (r = –0.71, P < 0.05) 
but not in NT individuals (r = –0.014; P < 0.05) (Figure 2).
discussion
The major findings of this study are that: (i) Despite the 
absence of OSA and the similar overall sleep efficiency and 
Figure 1. Systolic blood pressure (BP) (a), diastolic blood pressure (B), and heart rate (c) at the beginning of arousal from sleep and at the maximal 
(peak) response during arousal. The solid line represents the hypertensive group and the dashed line the normotensive group in the study. *P<0.05 
 differences between groups; †P<0.05 vs. differences within groups.
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architecture in the HT and NT groups in the study, HT 
patients had on average a twofold greater the number of 
arousals during sleep than did the NT subjects; and (ii) the 
magnitude of the increase in systolic BP during spontane-
ous arousal during NREM sleep was significantly greater in 
the HT patients than in the NT subjects. Although transient, 
the repetitive and frequent surges in BP triggered by arousals 
may be clinically relevant in HT patients.
Arousal is a marker of sleep fragmentation accompanied 
by a sudden, transient increase in the level of vigilance or 
spontaneous oscillations in the level of vigilance.20 It also 
represents an important physiological preparation in antici-
pation of rapid reaction or action when waking from sleep.21 
Although arousal may represent a physiological mechanism, 
it also provokes a significant increase in HR, BP,22 ventila-
tion,23–25 and cerebral blood flow.26 In some circumstances, 
frequent arousals may be potentially harmful. Momentary 
increases in muscle sympathetic nervous activity and BP 
associated with arousal from sleep during the N2 of NREM 
sleep27 provide insights into potential mechanisms whereby 
arousal from sleep can contribute in part to the initiation 
of cardiac events. For instance, Morrell et al.28 using a large 
population from the Wisconsin Sleep Cohort Study, found 
that sleep fragmentation (defined as the total number of 
awakenings and shifts to stage 1 sleep divided by the total 
sleep time) was independently associated with sustained 
higher levels of systolic BP in the awake state in individu-
als without overt sleep-disordered breathing, suggesting that 
repeated arousals may contribute to a sustained increase in 
BP. Another observational study29 suggested a link between 
arousal-related transient increases in BP and daytime hyper-
tension in a group of habitual heavy snorers without OSA. 
Our study extends these findings by showing that the fre-
quency of arousals in HT patients is greater and promotes 
a greater BP response than in appropriate control subjects.
The hemodynamic consequence of arousals from sleep as 
assessed with beat-by-beat BP monitoring has been poorly 
understood. In healthy individuals, arousals induced by 
auditory tones during sleep promote abrupt hemodynamic 
changes, characterized by increases in BP and HR.30,31 The 
simultaneous increase in HR and BP during spontane-
ous arousal suggests that the baroreflex is rapidly reset or 
overwhelmed by the arousal stimuli.21 Furthermore, previ-
ous studies show that spontaneous arousals during NREM 
sleep32 or auditory arousals from sleep consistently reduce 
the latency of sympathetic bursts, which may reflect attenu-
ated baroreflex control.33 In support of these previous find-
ings, we have observed that spontaneous arousals abruptly 
induce a more prominent increase in systolic BP in HT 
patients than in NT subjects during the N2 of NREM sleep 
period. Both the NT subjects and HT patients in our study 
exhibited an increase in HR during arousals. The increase 
in HR is probably a marker of a surge in sympathetic activ-
ity that occurs in response to arousal, regardless of the BP 
status of the subject. Interestingly, we observed an inverse 
correlation between the increase in BP with arousal and 
the duration of arousal. It is possible that baroreflex control 
is impaired in HT patients during abrupt transitions from 
sleep to wakefulness. This finding should be explored in fur-
ther investigations.
Table 3. Duration of electroencephalographic arousal and time 
taken to initiate and reach peak systolic blood pressure responses 
following onset of arousal in study subjects
Variables NT HT P
Time to initiate response, 
seconds
0.47 ± 0.1 0.51 ± 0.1 0.67
Time to reach peak response, 
seconds
5.9 ± 0.6 6.1 ± 0.6 0.86
Electroencephalographic 
duration of arousal, seconds
9.8 ± 0.4 9.5 ± 0.6 0.64
Duration of arousal minus time 
to beginning of response, 
seconds
9.4 ± 0.4 9.0 ± 0.6 0.61
Values are in means ± SEM.
Figure 2. Relationship between systolic blood pressure (BP) and duration of arousal in normotensive and hypertensive study groups.
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The present study was not designed to explore the potential 
mechanisms by which hypertension can promote sleep dis-
ruption in humans. However, recent experimental data have 
shown that spontaneously HT rats have more frequent inter-
ruptions during quiet sleep34 than do NT rats. Interestingly, 
sleep interruptions in spontaneously HT rats occurred in par-
allel to surges in sympathetic activity.35 In addition, an alpha-
1-adrenergic antagonist reversed, at least partly, the poor sleep 
quality of spontaneously HT rats, suggesting that exacerbated 
sympathetic activation is a main mechanism linking hyper-
tension and sleep fragmentation. It has been reported that 
norepinephrine is one of the main neurotransmitters in the 
monoaminergic arousal system and is prominently implicated 
in arousal and waking in conjunction with the cholinergic 
system and orexinergic neurons.36–38 In addition, it is possi-
ble that HT patients have not only a poorer quality of sleep 
but also a shorter sleep time than do NT individuals. In the 
present study, the HT group had a mean sleep time that was 
almost 1 hour shorter than that of the NT group. Although 
this difference was not significant, this lack of significance 
most likely reflects the small sample size in the study.
Our study has some strengths and limitations that should be 
addressed. A strength of our study was the simultaneous avail-
ability of polysomnographic data and data from hemodynamic 
monitoring during sleep. In addition, we selected the study 
patients and controls carefully. In particular, we performed 
screening tests to exclude secondary forms of hypertension 
(including OSA) in the HT patients. We also carefully with-
drew medications 2 weeks before the experiments in our study 
to exclude the confounding effects of antihypertensive drugs.39 
The limitations of the study included: (i) Its small sample size, 
which may have contributed to the lack of a difference in the 
baseline characteristics of the study groups in terms of gender, 
and the lack of a difference in the sleep duration. We would like 
to emphasize that our sample size was limited by the criteria 
for inclusion/exclusion of study subjects, including withdrawal 
from drugs and measurement of beat-by-beat BP during full-
night polysomnography, which requires constant monitor-
ing of the device used for measurement of BP. (ii) The use of 
noninvasive methods to determine BP during sleep. However, 
the Portapres is a validated system for the continuous meas-
urement of BP,17 and can be used in individuals under stable 
conditions; (iii) Our analysis was limited to the N2 of NREM 
sleep. However, the N2 is the most common phase of sleep (> 
60% of total sleep). (iii) To avoid potentially excessive moni-
toring during sleep, we did not perform 24-hour ambulatory 
BP monitoring of our subjects. We therefore cannot ignore the 
possibility that some of the HT patients in our study would 
have had a non-dipping pattern of BP.
In conclusion, the present study suggests that HT patients 
have more sleep fragmentation and a significantly higher sys-
tolic BP surge during spontaneous arousals than do NT indi-
viduals. Although sleep fragmentation may at least in theory 
be explained by a hyperadrenergic state, the exacerbated BP 
response on arousal of patients with hypertension may reflect 
an impaired autonomic nervous regulatory process observed 
in HT patients. These findings may partly explain the major 
risk of morbidity attributed to a surge in night-time BP in 
HT patients observed in epidemiological studies done with 
24-hour BP monitoring. Further studies are necessary to 
elucidate potential pathways for night-time surges in BP in 
primary hypertension and to determine whether a chrono-
tropic approach to the treatment of such hypertension or 
nonpharmacological interventions will reduce sleep frag-
mentation and surges in BP during sleep in individuals with 
primary hypertension.
acknowledgMents
This study was supported by Fundação de Amparo à 
Pesquisa do Estado de São Paulo, São Paulo-SP and in part 
by Fundação Zerbini, São Paulo-SP. Carlos E.V. Garcia was 
supported by FAPESP (#2010/18183–6). Carlos E.  Negrão 
(# 301867/2010-0) was supported by Conselho Nacional de 
Pesquisa (CNPq).
disclosure
The authors have no conflicts of interest to declare.
reFerences
 1. Pickering TG, Kario K. Nocturnal non-dipping: what does it augur? 
Curr Opin Nephrol Hypertens 2001; 10:611–616.
 2. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, 
Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood 
pressure and 10-year risk of cardiovascular and noncardiovascular 
mortality: the Ohasama study. Hypertension 2005; 45:240–245.
 3. Yilmaz MB, Yalta K, Turgut OO, Yilmaz A, Yucel O, Bektasoglu G, 
Tandogan I. Sleep quality among relatively younger patients with ini-
tial diagnosis of hypertension: dippers versus non-dippers. Blood Press 
2007;16:101–105.
 4. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of 
sleep apnea. Physiol Rev 2010; 90:47–112.
 5. Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger 
EM, Lorenzi-Filho G. Characteristics and predictors of obstruc-
tive sleep apnea in patients with systemic hypertension. Am J Cardiol 
2010;105:1135–1139.
 6. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure “dip-
ping” and “non-dipping” in obstructive sleep apnea syndrome patients. 
Sleep 1996;19:382–387.
 7. Huang Y, Mai W, Hu Y, Wu Y, Song Y, Qiu R, Dong Y, Kuang J. Poor 
sleep quality, stress status, and sympathetic nervous system activation 
in nondipping hypertension. Blood Press Monit 2011;16:117–123.
 8. Friedman O, Bradley TD, Ruttanaumpawan P, Logan AG. Independent 
association of drug-resistant hypertension to reduced sleep duration 
and efficiency. Am J Hypertens 2010;23:174–179.
 9. Drager LF, Ueno LM, Lessa PS, Negrão CE, Lorenzi-Filho G, Krieger 
EM. Sleep-related changes in hemodynamic and autonomic regulation 
in human hypertension. J Hypertens 2009;27:1655–1663.
 10. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin 
Questionnaire to identify patients at risk for the sleep apnea syndrome. 
Ann Intern Med 1999; 131:485–491.
 11. Johns MW. A new method for measuring daytime sleepiness: the 
Epworth sleepiness scale. Sleep 1991;14:540–545.
 12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, 
Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccela 
EJ. Joint National Committee on Prevention, Detection, Evaluation, 
and treatment of High Blood Pressure. National Heart, Lung, and 
Blood Institute; National High Blood Pressure Education Program 
Coordinating Committee. Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure. Hypertension 2003;42:1206–1252.
 at U
niversidade de SÃ£o Paulo on July 1, 2014
http://ajh.oxfordjournals.org/
D
ow
nloaded from
 
American Journal of Hypertension 26(5) May 2013 623
Effects of Frequent Arousals in Primary Hypertension
 13. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex 
control of sympathetic nerve activity in essential and secondary hyper-
tension. Hypertension 1998; 31:68–72.
 14. Grassi G, Seravalle G, Turri C, Bolla G, Mancia G. Short-versus long-
term effects of different dihydropyridines on sympathetic and barore-
flex function in hypertension. Hypertension 2003;41:558–562.
 15. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, 
Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep 
apnea. Am J Respir Crit Care Med 2005;172:613–618.
 16. Ueno LM, Drager LF, Rodrigues AC, Rondon MU, Braga AM, Mathias 
W Jr, Krieger EM, Barretto AC, Middlekauff HR, Lorenzi-Filho G, 
Negrão CE. Effects of exercise training in chronic heart failure patients 
with sleep apnea. Sleep 2009;32:637–647.
 17. Imholz BP, Langewouters GJ, van Montfrans GA, Parati G, van 
Goudoever J, Wesseling KH, Wieling W, Mancia G. Feasibility of ambu-
latory, continuous 24-h finger arterial pressure recording. Hypertension 
1993;21:65–73.
 18. Rechtstaffen A, Kales A, eds. A Manual of Standardized Terminology, 
Techniques and Scoring System for Sleep Stages of Human Subjects. 
Washington, DC: U.S. Government Printing Office, 1968.
 19. Iber C, Ancoli-Israel S, Chesson Jr A, Quan SF. The American Academy 
of Sleep Medicine. The AASM Manual for the Scoring of Sleep and 
Associated Events: Rules, Terminology and Technical Specifications. 
Darien, IL: American Academy of Sleep Medicine, 2007, p 37.
 20. Hala’sz P, Terzano M, Parrino L, Bo´dizs R. The nature of arousal in 
sleep. J Sleep Res 2004;13:1–23.
 21. Murali NS, Svaticova A, Somers VK. Cardiovascular physiology and 
sleep. Front Biosci 2003;8:s636–s652.
 22. Davies RJ, Belt PJ, Roberts SJ, Ali NJ, Stradling JR. Arterial blood 
pressure responses to graded transient arousal from sleep in normal 
humans. J Appl Physiol 1993; 74:1123–1130.
 23. Jordan AS, Eckberg DJ, Catcheside PG, McEvoy RD. Ventilatory 
response to brief arousal from non-rapid eye movement sleep is 
greater in men than in women. Am J Respir Crit Care Med 2003; 
168:1512–1519.
 24. Badr MS, Morgan BJ, Finn L, Toiber FS, Crabtree DC, Puleo DS, 
Skatrud JB. Ventilatory response to induced auditory arousals during 
NREM sleep. Sleep 1997; 20:707–714.
 25. Carley DW, Applebaum R, Basner RC, Onal E, Lopata M. Respiratory 
and arousal responses to acoustic stimulation. Chest 1997;112: 
1567–1571.
 26. Bangash MF, Xie A, Skatrud JB, Reichmuth KJ, Barczi SR, Morgan BJ. 
Cerebrovascular response to arousal from NREM and REM sleep. Sleep 
2008;31:321–327.
 27. Somers VK, Mark E, Dyken MD, Mark AK, Abboud FM. Sympathetic 
nerve activity during sleep in normal subjects. N Engl J Med 
1993;328:303–306.
 28. Morrell MJ, Finn L, Kim H, Peppard PE, Badr MS, Young T. Sleep frag-
mentation, awake blood pressure, and sleep-disordered breathing in a 
population-based study. Am J Respir Crit Care Med 2000;162:2091–2096.
 29. Lofaso F, Coste A, Gilain L, Harf A, Guilleminault C, Goldenberg F. 
Sleep fragmentation as a risk factor for hypertension in middle-aged 
nonapneic snorers. Chest 1996;109:896–900.
 30. O’Driscoll DM, Meadows GE, Corfield DR, Simonds AK, Morrell MJ. 
Cardiovascular response to arousal from sleep under controlled condi-
tions of central and peripheral chemoreceptor stimulation in humans. 
J Appl Physiol 2004;96:865–870.
 31. Trinder J, Allen N, Kleiman J, Kralevski V, Kleverlaan D, Anson K, Kim 
Y. On the nature cardiovascular activation at an arousal from sleep. 
Sleep 2003; 26:543–551.
 32. Xie A, Skatrud JB, Puleo DS, Morgan BJ. Arousal from sleep shortens 
sympathetic burst latency in humans. J Physiol 1999;515:621–628.
 33. Morgan BJ, Crabtree DC, Puleo DS, Bard MS, Toiber F, Skatrud BJ. 
Neurocirculatory consequences of abrupt change in sleep state in 
humans. J Appl Physiol 1996;80:1627–1636.
 34. Kuo TB, Shaw FZ, Lai CJ, Lai CW, Yang CC. Changes in sleep patterns 
in spontaneously hypertensive rats. Sleep 2004;27:406–412.
 35. Kuo TB, Chen CY, Lai CT, Chuan TY, Wu WY, Tsai SC, Yang CC. Sleep 
disturbance among spontaneously hypertensive rats is mediated by an 
α1-adrenergic mechanism. Am J Hypertension 2012 Jul 5. doi: 10.1038/
ajh.2012.93. [Epub ahead of print]
 36. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and 
circadian rhythms. Nature 2005;437:1257–1263.
 37. Aston-Jones G, Gonzalez M, Doran S. In Gregory AO, Schwartz MA, 
Frazer A (eds). Brain Norepinephrine: Neurobiology and Therapeutics. 
Cambridge, UK: Cambridge University Press, 2007, pp 157–194.
 38. Mitchell HA, Weinshenker D. Good night and good luck: norepineph-
rine in sleep pharmacology. Biochem Pharmacol 2010;79:801–809.
 39. Nerbass FB, Pedrosa RP, Genta PR, Drager LF, Lorenzi-Filho G. 
Calcium channel blockers are independently associated with short 
sleep duration in hypertensive patients with obstructive sleep apnea. J 
Hypertens 2011;29:1236–1241.
 at U
niversidade de SÃ£o Paulo on July 1, 2014
http://ajh.oxfordjournals.org/
D
ow
nloaded from
 
